As C17 is expressed in the joint and does not appear to act as a pro-inflammatory factor, we chose to investigate the impact of C17 expression in the context of CAIA, an in vivo model of acute joint inflammation and joint erosion. The gene discussed is CYTL1; the disease is inflammatory response.